Azizi Narges, Zangiabadian Moein, Seifi Golnoosh, Davari Afshan, Yekekhani Elham, Safavi-Naini Seyed Amir Ahmad, Berger Nathan A, Nasiri Mohammad Javad, Sohrabi Mohammad-Reza
School of Medicine, Tehran University of Medical Sciences, Tehran 1416634793, Iran.
Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman 7616913555, Iran.
Cancers (Basel). 2023 May 16;15(10):2778. doi: 10.3390/cancers15102778.
This study aimed to investigate the risk of gastric cancer (GC) in abnormal body mass index (BMI) groups. A systematic search was carried out on Embase, PubMed/Medline, and Scopus from January 2000 to January 2023. The pooled risk ratio (RR) with a 95% confidence interval (CI) was assessed using a random-effect model. Thirteen studies with total of 14,020,031 participants were included in this systematic review. The pooled RR of GC was 1.124 (95% CI, 0.968-1.304, I: 89.08%) in underweight class, 1.155 (95% CI, 1.051-1.270, I: 95.18%) in overweight class, and in 1.218 (95% CI, 1.070-1.386, I: 97.65%) obesity class. There is no difference between cardia and non-cardia gastric cancer, while non-Asian race and female gender have higher risk of cancer, as Meta-regression of obesity and overweight classes showed. These findings suggest that there is a positive association between excess body weight and the risk of GC, with a higher impact in women than men and in non-Asian than Asian populations. Since abnormal weight is tied to various diseases, including GC, healthcare experts, and policymakers should continue interventions aiming to achieve a normal BMI range.
本研究旨在调查体重指数(BMI)异常组患胃癌(GC)的风险。于2000年1月至2023年1月在Embase、PubMed/Medline和Scopus上进行了系统检索。使用随机效应模型评估合并风险比(RR)及95%置信区间(CI)。本系统评价纳入了13项研究,共有14,020,031名参与者。体重过轻组GC的合并RR为1.124(95%CI,0.968 - 1.304,I:89.08%),超重组为1.155(95%CI,1.051 - 1.270,I:95.18%),肥胖组为1.218(95%CI,1.070 - 1.386,I:97.65%)。贲门癌和非贲门癌之间无差异,而如肥胖和超重组的Meta回归所示,非亚洲种族和女性患癌风险更高。这些发现表明,体重超标与GC风险之间存在正相关,对女性的影响高于男性,对非亚洲人群的影响高于亚洲人群。由于体重异常与包括GC在内的各种疾病相关,医疗保健专家和政策制定者应继续开展干预措施,以实现正常的BMI范围。